glp 1 for mash FDA Approves Wegovy® as First Treatment Semaglutide targets MASH molecular pathways

On the cardiovascular side, the SUSTAIN-6 trial in 2016 was one of the first to report a significant reduction in major adverse cardiovascular events with semaglutide in adults with type 2 diabetes and high cardiovascular risk (Marso et al., NEJM, 2016)

J Alzheimers Dis (2019) 70(3):793810

phentermine is also contraindicated in pregnancy where licensed [2] Diabetic retinopathy : Rapid improvement in blood glucose with semaglutide may temporarily worsen diabetic retinopathy in some patients [11] [12] When to seek medical attention : Call 999 immediately for severe chest pain, signs of heart attack or stroke, or severe allergic reactions

The guidelines for the management of endocrine irAEs, provided by the American Society of Clinical Oncology 16 and the Society for Endocrinology in the United Kingdom, 17 recommend testing thyroid function as part of routine clinical monitoring of therapy

Saha, S., Chant, D